In the news: Pfizer's China plant hid failures, U.S.-China tech deals cause national security concerns and Ctrip and Qunar merge

This week the FDA found Pfizer's plant in China falsified records and used old ingredients, a U.S. defense group report questioned the local partnerships of IBM, Cisco and Microsoft and China's leading travel service companies combined

3 minute readNovember 02, 2015 at 08:04 PM
By
Katherine Jo
& clp articles
FDA team says Pfizer China plant hid failures This incident provides Chinese partners a nice what-not-to-do list whiledoing R&D for foreign firms. Falsifying quality control and manufacturing records, using old ingredients and hiding documents while the inspectors are on

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)